The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...
Moderna (MRNA) said that the two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna’s trivalent vaccine against ...
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...
Robert F. Kennedy Jr, a vaccine critic and the newly-appointed US health secretary, thanked "MAHA moms" before senators voted ...
The vote capped a remarkable rise for Robert F. Kennedy Jr., who was confirmed by a Republican Senate in a chamber where his ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
WASHINGTON -- The Senate is expected to vote Thursday on the confirmation of Robert F. Kennedy Jr ., a prominent lawyer and ...
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.